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Background: Training in patient and public involvement (PPI) is recommended, yet little is known about what
training is needed. We explored researchers’ and PPI contributors’ accounts of PPI activity and training to inform
the design of PPI training for both parties.
Methods: We used semi-structured qualitative interviews with researchers (chief investigators and trial managers)
and PPI contributors, accessed through a cohort of clinical trials, which had been funded between 2006 and 2010.
An analysis of transcripts of audio-recorded interviews drew on the constant comparative method.
Results: We interviewed 31 researchers and 17 PPI contributors from 28 trials. Most researchers could see some
value in PPI training for researchers, although just under half had received such training themselves, and some had
concerns about the purpose and evidence base for PPI training. PPI contributors were evenly split in their
perceptions of whether researchers needed training in PPI. Few PPI contributors had themselves received training
for their roles. Many informants across all groups felt that training PPI contributors was unnecessary because they
already possessed the skills needed. Informants were also concerned that training would professionalise PPI
contributors, limiting their ability to provide an authentic patient perspective. However, informants welcomed
informal induction ‘conversations’ to help contributors understand their roles and support them in voicing their
opinions. Informants believed that PPI contributors should be confident, motivated, intelligent, focussed on helping
others and have relevant experience. Researchers looked for these qualities when selecting contributors, and spoke
of how finding ‘the right’ contributor was more important than accessing ‘the right’ training.
Conclusions: While informants were broadly receptive to PPI training for researchers, they expressed considerable
reluctance to training PPI contributors. Providers of training will need to address these reservations. Our findings
point to the importance of reconsidering how training is conceptualised, designed and promoted and of providing
flexible, learning opportunities in ways that flow from researchers’ and contributors’ needs and preferences. We also
identify some areas of training content and the need for further consideration to be given to the selection of PPI
contributors and models for implementing PPI to ensure clinical trials benefit from a diversity of patient perspectives.
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Patient and public involvement (PPI) in health research
has been promoted within the United Kingdom at the
highest levels for some time and it is increasingly en-
couraged internationally [1,2]. For research projects and
programmes funded by some health and social care
funders, PPI is mandatory, and for others, it is strongly
encouraged, including in the United States, where it is
known as stakeholder engagement, and in Australia,
where it is termed consumer and community participa-
tion [2-6]. While the evidence on PPI activity in research
is expanding, PPI training has received little research at-
tention. Such training demands time and resources and
it also has the potential to shape the future conceptual-
isation, implementation and impact of PPI in research. It
therefore warrants research scrutiny.
INVOLVE [7], which is the UK-based advisory body
on PPI in health and social care research, report that
most PPI training courses have been developed within
particular organisations or in the context of individual
research projects. They define training broadly as any
activity ‘that aims to help members of the public and re-
searchers develop their knowledge, skills and experience
to prepare them for public involvement in research’ [7].
An examination of training and educational provision of
PPI in research confirms the diversity of aims, content
and delivery of training. For example, education and train-
ing for PPI contributors ranges from a formally assessed
and certificated year-long course on the discovery, testing
and evaluation of medical products and technologies [8],
to informal workshops that focus on helping contributors
to identify suitable research roles and build confidence
[9,10]. Examples of training for researchers are almost
as variable, ranging from formal modules on the theory,
policy and current practice of PPI within accredited
Master’s courses [10,11], to single ‘awareness raising’
workshops on the aims and implementation of PPI in
research [12].
While this diversity of training may be appropriate, it
raises questions about how to ensure training is fit for
the purpose. INVOLVE proposes that training be pro-
vided for both PPI contributors and researchers [7,13],
tailored to the needs and roles of learners, delivered on
an ongoing basis and that allows contributors and
researchers to learn from each other [7]. These princi-
ples were drawn from consultations with over 30 stake-
holders who had direct experience of PPI training either
as providers or recipients. However, few details of the
methods of consultation are available, and little is known
about the perspectives of those researchers and PPI con-
tributors who have not participated in training. A key
consideration for any training is that it engages with the
diversity of learners’ needs and is meaningful from their
perspective [14]. Insights on how members of the researchcommunity perceive PPI training, whether or not they
have had prior experience of such PPI training, will help
to ensure its relevance and uptake.
This study aimed to provide such evidence in the con-
text of PPI activity within randomised controlled trials
(RCTs), a type of research thought particularly likely to
benefit from PPI [15]. As part of a wider study of re-
searchers’ and contributors’ perspectives on PPI, we ex-
plored their views and experiences of training in PPI and
of related issues such as the selection and diversity of
PPI contributors. We sampled informants from a cohort




This qualitative study was part of the EPIC (Evidence base
for Patient and Public Involvement in Clinical trials) pro-
ject, which investigated PPI in a cohort of all RCTs in re-
ceipt of funding from the National Institute for Health
Research (NIHR) Health Technology Assessment (HTA)
programme between 2006 and 2010 [16,17], and for which
relevant documents were available. Other components of
EPIC included a review of PPI statements in the grant ap-
plications for each of the RCTs and surveys of chief inves-
tigators (CIs), PPI contributors and trial managers (TMs)
on their views and experiences of PPI within these trials.
For the qualitative study, we invited CIs, PPI contributors
and TMs who had responded to the survey to be inter-
viewed. While CIs and TMs might be anticipated to have
similar perspectives, it was important to access both
groups, as their roles in research are distinctive. Whereas
TMs are researchers who usually only have contact with
PPI contributors in the context of a trial, CIs often have
clinical as well as research roles. Arising from their clinical
roles, CIs might feel that they have knowledge of patients’
perspectives, which could influence how they value PPI.
The interviews explored informants’ views and experi-
ences of PPI and of training and support for PPI. In con-
junction with this, we also explored how PPI contributors
were selected into their roles. We describe the qualitative
study methods in detail elsewhere [18].
Ethics statement
We obtained ethical approval from the University of Liv-
erpool Research Ethics Committee (Ref: RETH000489).
All participants gave informed consent.
Recruitment and sampling
We initially aimed to sample 25 trials and to use details
provided on trial grant application forms to contact CIs.
We initially sampled CIs for maximum diversity based
on their survey responses to questions regarding their
views on PPI, motivations for including PPI and who
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However, we eventually invited almost all CIs who had
responded to the survey and indicated an interest in being
interviewed. We mainly accessed PPI contributors through
CIs, by asking them to forward an email from the EPIC
research team, which had invited PPI contributors to re-
spond to the survey. We obtained contact details for TMs
from clinical trial units, trial websites and protocols, or via
CIs. As we were principally interested in the accounts of
CIs and PPI contributors, we only invited the TMs for
interview when a CI or PPI contributor from the same trial
had been interviewed.
Interviews
LD, a psychologist, conducted audio-recorded semi-
structured telephone interviews with informants between
April 2013 and November 2013. LD explained that study
data would be anonymised and kept confidential. Topic
guided interviews were conversational to allow informants
to freely voice their views and experiences of training for
both researchers and PPI contributors, including the se-
lection of PPI contributors and the provision of induction
and support for their role. In order to minimise the risk of
idealised accounts, LD adopted a neutral stance in her
interviewing and used questions that were exploratory ra-
ther than ones that might be perceived as judgemental or
interrogatory. We tailored the topic guides (summarised
in Table 2) for each of the three informant groups (CI, PPI
contributor and TMs) and periodically reviewed and de-
veloped the guides in the light of the ongoing dataTable 1 Survey responses used in initial sampling of chief inv
responses for interview subsample and survey sample
Question 1: In general, what is your personal view on patient and
public involvement (PPI)?
PPI should always be included in a research study
PPI can be beneficial but is not always necessary
I am not convinced of the benefits of PPI
Question 2*: What motivated you to include PPI in your trial?
I think including PPI is the right thing to do
I have previous experience of the benefits of PPI
PPI was a requirement for research funding
A PPI contributor offered their help
Other







*CIs could provide more than one response to questions 2 and 3.collection and analysis. Interviewing paralleled the ana-
lysis and continued until theoretical saturation [19] had
been reached. Interviews were transcribed using an
‘efficient’ verbatim style that involved transcribing the
content of informants’ accounts, rather than detailed
features of speech such as sub-vocalisations and hesita-
tions etcetera. All transcripts were checked for accuracy
and anonymised.
Analysis
Analysis was informed by the principles of the constant
comparative method [20,21], with elements of content
analysis [22]. We drew on the concept of catalytic validity
[23], which emphasises that findings should go beyond de-
scription to offer insights with potential to contribute to
practice. Our approach was broadly interpretive; that is, as
well as considering the manifest content of informants’
accounts, we looked at how participants described their
perspectives and what was latent or deemphasised in their
accounts, as well as what was emphasised [24]. While the
emphasis in qualitative research is on being inductive,
there were some deductive elements to our analysis; for
example, we drew on current definitions of training [7] to
inform the analysis. We used procedures to support rigour
in qualitative research [25]. To ensure a contextualised
analysis, we reviewed whole transcripts as well as focusing
on particular sections. We analysed transcripts at the in-
formant group level for evidence of CI, PPI contributor
and TM views and experiences of training and support for




within CI survey n(%)
12 (57) 42 (52)
8 (38) 35 (43)
1 (5) 4 (5)
15 (76) 51 (63)
12 (57) 45 (56)
8 (38) 38 (47)
1 (5) 4 (5)
2 (10) 9 (11)
14 (67) 51 (63)
2 (10) 14 (17)
2 (10) 13 (16)
10 (48) 24 (30)
4 (19) 11 (14)
3 (14) 10,
Table 2 Summary of interview topics covered
Researchers Patient and public involvement (PPI) contributors
Expectations Expectations
Researchers understanding of PPI Previous experience of being a PPI contributor
Experience of including PPI in research Expectations for what working on the current trial would be like
Any initial goals or plans for PPI in current trial
What happened? What happened?
Stage of PPI implementation How did they become involved in the trial?
Identifying and selecting PPI contributors PPI contributor’s role
Roles of the PPI contributors Relationship with research team
Overall experience of including PPI in the current trial
Impact Impact
Perceived contributions of PPI Any differences made to the trial as a result of their input
Challenges of including PPI Any benefits to themselves of being involved
Any challenges of being involved
Training and support Training and support
What training and support had been given to PPI contributors
and views on this?
What training and support had they received and what are their views
of training for PPI contributors?
Views and experiences of PPI training for researchers What are their views on PPI training for researchers?
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formant groups to explore convergences and divergences
between them. We also looked for deviant cases and used
these to develop our analysis.
LD led the analysis, reading transcripts several times
to develop open codes and liaising with BY, who also
read multiple transcripts. LD and BY met regularly to
compare interpretations of the data and review the on-
going analysis. Open coding took place at multiple levels
from line-by-line coding of detailed descriptions to the
general stance informants took towards PPI and training.
These codes were grouped into categories and organised
into a framework using NVivo 9 software. Categories were
amended on an ongoing basis to ensure these reflected
new data whilst accounting for deviant cases. To support
our interpretations, we present illustrative extracts from
the data. Extract codes were used to indicate the in-
formant group CI, TM, PPI (1 or 2 if there were mul-




We recruited informants from 28 trials, which had been
conducted in a variety of settings, and evaluated a range
of interventions (Table 3). For 14 of the 28 trials, we
interviewed one informant, for nine trials we interviewed
two informants, for four trials we interviewed three
informants, and for two trials we interviewed four infor-
mants. Figure 1 shows the recruitment of CIs and PPIcontributors: 21/41 (51%) CIs and 17/29 (59%) PPI con-
tributors were interviewed out of those invited. Regard-
ing TMs, one trial did not have a TM at the time of our
study, and we could not obtain contact details for three
TMs. We invited TMs from the remaining 24 trials; of
these, nine TMs did not respond, five declined and 10
(42%) were interviewed. PPI contributors who responded
to the survey were mostly accessed via CIs, with one
accessed via the chairperson of a trial steering commit-
tee. On average interviews lasted 45 minutes.
Induction and support: informal and implicit
We wanted to explore how informants conceptualised
‘induction’, and ‘support’ within the context of PPI with-
out constraining their responses, so we avoided defining
these terms during the interviews. Most informants
characterised induction as a one-off informal ‘conversa-
tion’ between PPI contributors and researchers, rather
than a formal or structured process. Inductions typically
involved researchers explaining to PPI contributors what
researchers ‘saw their input might be” (CI - 2) and ‘what
the study was about’ (TM - 8), with PPI contributors be-
ing ‘given all the data, the explanation of what the trial
was about’ (PPI - 6). Therefore, while both researchers
and PPI contributors tended to describe ‘induction’ as an
informal encounter, these were mostly one-way ex-
changes, with researchers being positioned as providers
and PPI contributors as recipients. Neither party spoke
of entering into a negotiation about what the role of the
PPI contributors would entail.
Table 3 Informant interviewed, trial setting and intervention type
Trial Chief investigator (CI) or senior
team member interviewed?





1 Y Y N Community Education and exercise
2 Y Y N Tertiary Device
3 Y Y Y Secondary Education
4 Y N N Tertiary Drug
5 Y N Y Secondary Surgical
6 Y Y N Secondary Exercise
7 Y Y N Primary Community care
8 Y Y (2 PPI contributors) Y Tertiary Drug
9 Y Y Y Secondary Device
10 Y N N Social care Exercise
11 Y Y (2 PPI contributors) Y Secondary Surgical
12 Y N N Secondary Device
13 Y N Y Secondary Drug
14 Y N N Secondary Surgical
15 Y Y Y Primary Exercise
16 Y N N Primary Exercise
17 Y N N Secondary Surgical
18 Y N Y Primary and secondary Exercise and community care
19 Y N N Primary Other
20 Y N N Emergency Community care
21 Y N Y Secondary Device
22 N Y N Secondary Surgical
23 N Y N Secondary Device
24 N Y N Tertiary Drug
25 N Y N Emergency Surgical
26 N Y N Secondary, Tertiary Surgical
27 N Y Y Emergency Drug
28 N Y N Secondary Device
*A primary setting is the first point of consultation for a patient within the healthcare system, for example a general practitioner. A secondary setting involves
healthcare provided by medical specialists who cannot be directly accessed by a patient, for example within a hospital outpatient clinic. A tertiary setting is
specialist consultative healthcare, on referral from primary or secondary care and that has personnel and facilities for advanced investigation and treatment, for
example a specialist cardiac unit.
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ceived an induction. When PPI contributors had not re-
ceived an induction, researchers and some PPI contributors
explained that the PPI contributor had previous experience
in a PPI role, and researchers had assumed an induction
was superfluous in these cases. However, other PPI contrib-
utors who reported not having received an induction indi-
cated that it would have been useful.
‘It would have been good to get a bit more of a sort of
formal induction at the beginning about what the trial
was, what my role was going to be’ (PPI - 9).Similarly, researchers and PPI contributors described
low key approaches to the support of PPI contributors,
emphasising how PPI contributors knew they could con-
tact researchers for support and advice if needed, al-
though it was rare for them to do so.
‘We did not say ‘look we will give you support in
this if you want it’, but I know that they had free
and instant access to me. I would get emails and I
would always respond, so even though it [support]
might not have been explicitly stated, it was
implicit’ (CI - 13).
Figure 1 Flow diagram illustrating chief investigator (CI) and patient and public involvement (PPI) contributor recruitment. The figure
provides a breakdown of CI and PPI contributor recruitment from the point at which potential informants were identified from those responding
to the survey.
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of thing […] she had my email; she had my phone
number and things, and the same for the project
administrator. So she always knew that she could
contact us if she needed to’ (TM - 27).
‘I haven’t taken up much of it [support] but I know that
the team, [name of CI] and his assistants have been
there if I’ve needed to contact them, which I haven’t
really, but I know that they’ve been there’ (PPI - 2).
Therefore, ‘offers’ of support for PPI contributors were
largely implicit. In their interviews, researchers spoke of
their readiness to provide support and contributors sensed
that support was available if needed, although it seemed
that both parties rarely discussed such support overtlyduring the course of PPI activities. Moreover, most infor-
mants saw support largely as synonymous with practical
or logistical help, such as assistance with travel arrange-
ments, rather than ongoing support to contributors in
core aspects of their roles. From our analysis of CIs’ ac-
counts, these roles included PPI contributors providing
advice on patient recruitment and information mate-
rials, choice of outcome measures and the acceptability
of the trial design. Although some PPI contributors felt
unclear about their role, only one spoke of accessing
support to address this.
‘I was in a learning process myself not knowing
exactly what I could do, and I kept returning things to
the professor saying, ‘I’ve been a bit pedantic here’ […]
and she would say, ‘Pedantic is what I’m looking for,
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not have noticed’. So it was me learning how to
approach the situation’ (PPI - 11-1).
As well as emphasising the informality of the induc-
tion process and the implicit nature of support, as we
explain in the following sections, all three groups of in-
formants spoke of their preference for informal ways of
learning about PPI over more formal or structured train-
ing, particularly for PPI contributors.
Training
Mirroring their accounts of induction, informants often
drew a distinction between formal training and informal
‘conversations’ about the trial. Most informants tended
to conceptualise ‘training’ as ‘formal’, structured courses.
A summary of the training needs that were identified by
researchers and PPI contributors can be found in Table 4.
Researchers on their own training: useful to a point
Of the 31 researchers interviewed, 18 had not had any
form of training in PPI, while 13 had accessed training
or attended an informal talk or workshop on PPI. These
had covered topics such as ‘how PPI should work’, how
to incorporate PPI into research, how to run focus
groups and how to identify and engage PPI contributors.
All researchers who had participated in these activities
had found them useful in discovering how to do PPI,
what had worked for others and how PPI can benefit re-
search. However, one CI commented that the formal
training he had received was too focussed on ‘how PPI
should work’ and that insufficient emphasis had been
given to ‘the practicalities of how to involve your pa-
tients’ (CI - 5).
Of the 18 researchers who had not received training,
nine indicated that they would like to receive training
and nine expressed reluctance. CIs who wanted trainingTable 4 Training needs identified by researchers and patient
Training for researche
Training needs reported by researchers • Guidance on how and
contributors
• How to get the most
• What is expected of c
• How PPI benefits rese
• Guidance on payment




• How to engage PPI coexplained that they would like guidance on how and when
to involve PPI contributors, how to optimise their input,
what is expected of PPI contributors, how PPI benefits re-
search and guidance on payment for PPI. Additionally, one
TM wanted to learn about the wider research community’s
expectations regarding the implementation of PPI:
‘A little bit more on how we can work together,
patients and researchers, and how we can benefit
from having a strong PPI involvement in this study […]
I’d like to learn a bit more on how things should be
done or how they are expected to be done’ (TM - 21).
Of the 21 CIs, 6 had no experience of PPI prior to the
current trial. Researchers who did not want training
commented that they already knew ‘how to do PPI’ usu-
ally because they had learnt about it ‘through experience
rather through any particular formal training’ (CI - 5).
While researchers, particularly CIs, generally described
one of the main challenges of PPI to be finding ‘suitable’
people, they did not identify this as a training need. Nor
did we find any evidence that researchers’ views on
training were influenced by their views on the value of
PPI. For example, some researchers who were sceptical
about the value of PPI felt that training would be useful
for certain topics. Conversely, some researchers who
spoke of PPI as ‘really important’ or ‘crucial’ were reluc-
tant to receive training because they could not envisage
what topics the training would cover, or felt that there
was insufficient knowledge of PPI in order to inform a
training course.
‘Hopefully your research project will come out with
sort of clearer guidelines about when and where PPI
input is useful, because I’m never quite sure myself
[…] I wouldn’t be keen on any training at the
moment’ (CI - 15).and public involvement (PPI) contributors
rs Training for PPI contributors
when to involve PPI • General research methods or design
out of contributors • Role expectations
• What happens in meetings
ontributors • Confidence to speak in meetings
arch
• How PPI and research works
• How ethics and funding works
ntributors • Being able to ask questions/ confidence
to speak up
• Role expectations
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researchers: useful to address specific difficulties
Of the 17 PPI contributors, nine felt that researchers
should receive training in PPI. Contributors pointed to
the use of jargon as one of the main challenges they faced.
Reflecting this, they indicated that researchers could bene-
fit from training on the importance of using plain English.
Some PPI contributors also pointed to the lack of role
clarity as a challenge they faced and reflecting this, they
spoke of understanding the public mindset, contributors’
roles and how to engage with them as priority areas for re-
searcher training.
‘I’d be told what […] the expectations of me were in
the team and what are the things I was supposed to
do in the team, and they [researchers] would have that
explained to them as well […] It would just be making
sure that people understood my role’ (PPI - 22).
Other PPI contributors felt that training researchers
was unnecessary, particularly as they saw CIs as individ-
uals who were used to ‘dealing with people’ and expected
researchers to have acquired the requisite knowledge and
experience or ‘at a level of um ability, shall we say, that
shouldn’t need much training’ (PPI - 11). A few PPI con-
tributors also felt that such interpersonal abilities could
not ‘be taught, it’s a question of interface and interaction
and experience with one another’ (PPI - 7).
There were indications that PPI contributors’ views on
training for researchers may be linked to their previous
PPI experience. Of the nine PPI contributors who felt
that researchers should receive training, six had little or
no experience of being a PPI contributor. Conversely, of
the five PPI contributors who felt that researchers did
not need training, four had previous experience of being
a PPI contributor.
Patient and public involvement contributors on their own
training: largely unnecessary and potentially detrimental
Of the 17 PPI contributors, only three had received
training for their role within the EPIC cohort trial. They
indicated that this training had focussed on research
processes including, ‘basic appraisal of clinical papers’,
‘general research training’, and what research is about
and good clinical practice, rather than the roles of PPI
contributors. All three contributors described the training
as useful, although the contributor whose training had
covered critical assessment of research papers focussed on
how it had informed her paid employment as a nurse ra-
ther than her PPI role.
‘I learned a lot […] I’m actually able [to] apply it to
other aspects of my work now because if we’re
looking at products in the area I work in, I can look atthe clinical papers attached to them and understand
more how to read them, so it has been a help to
me’ (PPI - 2).
The remaining 14 PPI contributors did not report having
received any training. Of all 17 PPI contributors, 15 indi-
cated that they did not want or need training, with most
explaining that a conversation at the beginning of their in-
volvement to clarify their role would be sufficient. Our
wider analyses had identified three main roles for contribu-
tors: oversight, managerial and responsive. Both PPI con-
tributors and researchers acknowledged that a contributor’s
training needs depended on the particular type of role they
had. In oversight roles contributors’ activities were formal
and often entailed being the sole PPI member on a trial
steering or data monitoring committees. Managerial roles
were also formal and usually entailed one PPI contributor
acting as a co-investigator or member of the trial manage-
ment group. Responsive PPI roles were typically more in-
formal than the other two types, with contributors being
approached for advice on an ‘as required’ basis. All the
contributors in our study had oversight or managerial roles
within the EPIC cohort trials. Some spoke of not needing
training because they had already acquired the necessary
skills for these roles through their employment or previous
experience as a PPI contributor. For example, a contributor
who described himself as having worked as a ‘senior man-
ager in industry’, and whose description of his role within
the trial resembled that of a manager, commented that
training was unnecessary because he was:
‘Well used to running meetings and keep people on
track […] I’m used to actually making decisions
and coming up with proper ways of getting things
done’ (PPI - 22).
His account stood in contrast to another contributor
who saw her role as more limited.
‘I can use a computer and I can use email and things
like that because of my job, […] but as far as training
is concerned, because my role is absolutely not to run
the trial or anything […] I’m not sure that training per
se is necessary’ (PPI - 11).
Despite the differing perceptions of their roles, both
contributors talked of how they already possessed the
skills their roles required and neither could therefore see
a need for training. Some PPI contributors gave passing
mention to how training may be useful for ‘other’ con-
tributors who had less experience.
‘I’ve had eight years of being a non-exec director, so I
know what is expected […] so no, I didn’t need it
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would need some training and familiarisation in how
it works’ (PPI - 26).
Two contributors were also concerned that training
could result in PPI contributors learning ‘too much’,
which would be detrimental to providing a patient per-
spective. For example, training could encourage contribu-
tors to look at issues ‘from a clinician’s point of view […]
once you’ve learnt too much I don’t believe that you’re a
lay person’ (PPI - 23/24). Interestingly, these PPI contribu-
tors spoke of such professionalisation in general or hypo-
thetical terms, rather than as something they struggled
with personally.
Researchers on training for patient and public involvement
contributors: better to select than train
Of the 31 researchers interviewed, 6 indicated that train-
ing would be of value for PPI contributors on their trial,
6 did not express an opinion and 19 felt that training was
unnecessary. Like the contributors, researchers in the lat-
ter group regarded PPI contributors as already possessing
the skills and experience that their roles required.
‘I don’t think that she [PPI contributor] was in any
way reserved about contributing and I think she
understood the role on the trial steering committee
[…] because she had had a role of representing
patients before’ (CI - 4).
Informants’ accounts of training were closely bound
up with their accounts of how to select PPI contributors,
and both researchers and PPI contributors implied that,
rather than training PPI contributors, it was often better
to select individuals who already possessed the attributes
necessary for their role:
‘It can take a lot of time to bring people up to
speed with the principle of trial design. And I’m not
saying that’s not necessarily a good thing to do but if
somebody’s already got that experience and knowledge
you’ve already overcome quite a big hurdle’ (CI - 9).
Six researchers echoed the concerns of the PPI con-
tributors who thought that training could over profes-
sionalise PPI contributors and therefore be detrimental
to their role:
‘If you train them then I think they’re probably aware
of more of what should be happening and they won’t
have such an objective view, whereas if they’re coming
at it almost totally fresh then they have more of the
perspective of if a patient received this information’
(TM - 18).‘What you really want from them is for them to be
kind of impartial and […] to really represent what the
patients and the public think. So if they are too kind
of clued up on research they might not actually be
representative of our target audience’ (TM - 13).
A few researchers also struggled to identify what the
content of training would be for PPI contributors: ‘I would
find it difficult to know what you could train people in’
(CI - 11). Researchers who felt that training would be
beneficial for contributors on the trial, pointed to general
research training such as research methods and the role of
PPI contributors as suitable topics. While researchers gen-
erally tended to emphasise that the particular PPI contrib-
utors on the EPIC cohort trial did not need training, some
pointed to circumstances when training might be useful.
For example, contributors who were ‘less experienced’
could benefit from training, particularly if they were to
have oversight or managerial roles.
‘Making sure that the person who is the PPI rep is
comfortable and confident to ask questions and to
query things […] that’s maybe when training actually
for the PPI, now I think about it, might be really
important’ (CI - 6).
‘If you’re expecting them to attend the trial steering
committee, if they’ve not done that type of thing
before, then I think some information and training
[…] around the topics that are going to be come up’
(TM - 18).
Need for ‘professional’ and ‘lay’ contributors
According to our informants, it was not just training
that could lead to the professionalisation of PPI contrib-
utors, cumulative experience in a PPI role could also do
this. Both researchers and PPI contributors distinguished
between “lay” and “professional” PPI contributors, al-
though the latter were not necessarily individuals with
professional employment backgrounds. Researchers in
particular described professional contributors as people
who ‘went around doing PPI’, implying that such individ-
uals had a level of experience and knowledge that set
them apart from other patients, whereas lay contributors
were ‘just […] people with the experience of whatever it
is you’re researching’ (CI −3). Professional contributors
were believed to get ‘less and less like the population the
more engaged they become’ (CI - 16), and increasingly
influenced by the ‘researcher mind set’ and unable to
contribute an authentic patient perspective. Conversely,
researchers acknowledged how difficulties could arise
when PPI contributors were ‘naïve’ to their role in re-
search. One CI spoke of a difficultly she had experienced
on a previous trial with a PPI contributor who had been
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proved’ (CI - 7) and others commented on how it was
helpful to have contributors who understood the research
process and the constraints on researchers.
‘When it works it works probably because we’ve got
people who are able to understand what we want of
them and are able to be quite articulate and succinct
and able to separate out their own stuff from the
problem on the table’ (CI - 20).
Some researchers were torn between wanting the ben-
efits that professional contributors brought and worrying
that they were hardly ‘representative’ of target partici-
pants. Others spoke of how this tension could be resolved
by involving both professional and lay PPI contributors in
trials. Whereas professional PPI contributors were be-
lieved to be suited to managerial or oversight roles, lay
PPI contributors were felt to be suited to responsive roles,
which required a ‘true’ patient perspective and where it
was possible to ‘come along and be yourself ’.
‘I was a little bit surprised to find that there were
these sort of professional PPI reps. I think it is good
because they come with an understanding of research,
but I think that’s where it’s really important that
you have a mix of people that you’re getting views
from, because I think if maybe people are too
research-savvy, they’re only going to think like
researchers and they’re not actually going to give
us a real patient perspective’ (CI - 6).
Selecting patient and public involvement contributors
Most researchers had identified PPI contributors through
a charity or patient organisation or indicated that the PPI
contributor was previously known to them, either through
earlier PPI work or as participants in a previous trial. Two
CIs had PPI contributors who were their own patients.
Sometimes CIs had sought or received recommendations
regarding the suitability of a potential PPI contributor from
other researchers, PPI contributors, patient organisations
or personal contacts. Only one CI reported having sent an
advert out through a patient organisation inviting people to
volunteer for the role of PPI contributor.
As noted above, informants from all groups described the
importance of selecting PPI contributors to suit their role.
As we illustrate in the list below of attributes and qualities
that informants thought a PPI contributor should posses,
all informant groups emphasised the importance of select-
ing contributors who could be confident and active in
meetings if they were to have oversight and managerial
roles, and spoke of how PPI contributors should be moti-
vated and have interests in the research or clinical area. Al-
though some informants, as we note above, commentedthat it was important for PPI contributors to have previous
experience of a PPI role, the lack of such experience could
be compensated for in other ways, for example, if contribu-
tors shared characteristics or experiences in common with
the participants to be targeted for a particular trial or had
an educational or employment background seen as relevant
to their role.
Attributes and qualities that informants thought patient
and public involvement (PPI) contributors should possess
 Confidence
‘You want them to be confident and capable of
presenting their view. So you don’t want somebody
who’s going to be shy. You don’t want somebody
who’s going to be easily intimidated’. (CI - 9)
‘They’ve [PPI contributors] got to be a bit of a
confident person to speak up in these kinds of
meetings. You’ve got lots of clinicians, they’re
talking about lots of things that the patient probably
doesn’t understand’. (TM - 5)
‘You do have to be confident to make your point.
So you’re working with clinicians, they talk quite
technical […] being happy to make your point can
be challenging, but I do it and I’m comfortable
doing it’. (PPI - 26) Motivation and commitment
‘Finding the right person who has the time and
the commitment and the interest’. (CI - 20)
‘Someone who’s interested in research […] who’s
willing to commit […] So if we wanted someone
on one of our steering committees they would
have to be able to commit to a certain number of
meetings a year and be happy to review
documents in time for meetings’. (TM - 9)
‘They [PPI contributors] should be passionate
people that really believe that they, they want to
try and make a difference’. (PPI - 7) Focus on the ‘greater good’
‘My PPI people were really good because they never,
ever […] brought it back down to themselves all the
time […] But in another study that I’ve got, we have
had that and it’s become quite draining to
everybody because the PPI […] person has become
very much preoccupied by getting their personal
healthcare improved’. (CI - 7)
‘An ability to see beyond their own particular
experience and maybe draw on the experience of
peers, others in the field’. (TM - 3)
Dudley et al. Trials  (2015) 16:190 Page 11 of 15‘They should be people who can look outside of
their immediate needs to the greater good […] if I
was particularly concerned about my condition
then it could override everything in terms of the
trial. I might want to steer it towards something
I’m particularly keen to have resolved or sorted.
So you need to have someone who sees the trial,
and understands the concept in the broadest
sense. And that the benefits may not indeed help
them’. (PPI - 26) Previous PPI experience
‘It’s useful [to have contributors with previous PPI
experience] because they have an understanding
both of the general world, if you can call it that,
and also of the research field, so, and of what their
researchers are expecting […] It probably does
help if they have had some experience before, but
it’s not always necessary’. (CI - 1)
‘We had people who, who had been [contributors]
on other randomised controlled trials so they, they
knew what we were getting at but […] you’re bound
to get somebody who… for whom it’s, it’s new but
as long as […] you’re not asking them to think
about something that they can’t possibly have any
familiarity with, then I think you can overcome the
lack of methodological experience’. (CI - 16) Experience of the target condition, patient group
or of interventions similar to those being
investigated‘One of the most important things is that they
represent the type of person that the study will be
directed at. There’s no point going for a fifty-year-
old guy when your study is about [condition] and
you’re going to be recruiting people who are under
24’. (CI - 19)
‘We often recruit more broadly than just patients
now. So it’s carers and people who work with frail
elderly patients who often have greater time and
as much insight as the patient themselves in many
ways’. (CI - 5)
‘It’s important that they’ve […] had experience
of having the type of operation that you’re
investigating, or the disease area that you’re
investigating, just so that they’ve got a better
perspective of what is important to the patient’.
(TM - 11)
‘[PPI contributors should be] people that have
experience of the condition […] it should be
condition-specific’. (PPI - 7) Intelligence and education
‘It’s got to be somebody who, is sort of, I don’t
know if intelligent is the right word, but who has a
lot of common sense basically. Obviously [they] do
need to be intelligent and be able to read
moderately complex stuff and understand fairly
complex things. You don’t want somebody who’s
not very bright’. (CI - 71201)‘You’ve got to be quite bright. I think some of
these documents are quite dense, so I think that
that’s important’. (PPI - 11)
‘You need fairly reasonably academic and, or
professional qualifications to do it, so it’s not for
the faint hearted […] I’ve got a university degree,
and I’ve written one or two books […] others
might be bewildered by it’ (PPI - 15).Discussion
Summary
Informants had some reservations about the need for
training in PPI, particularly in relation to training PPI
contributors. Very few contributors had received train-
ing for their roles, and many were reluctant to engage in
it. Researchers shared this lack of enthusiasm for train-
ing PPI contributors. However, informants did welcome
informal induction ‘conversations’ to help contributors
to understand their roles. Beyond this, they tended to
see training PPI contributors as redundant because, by
selection, they already possessed the necessary attributes.
Informants were also concerned that training and cumula-
tive experience in PPI roles could lead to the professional-
isation of contributors, limiting their ability to ‘represent’
the patient perspective. Researchers described a tension
between the need for contributors who could offer an au-
thentic patient perspective and a need for contributors
who could function in oversight and managerial roles (for
example as members of trial steering and managerial
groups, respectively). Some researchers commented that
this tension could be resolved by selecting particular PPI
contributors for particular roles. Rather than training con-
tributors, researchers favoured using their networks and
others’ recommendations to select individuals who already
possessed attributes perceived as important for the role. It
could be that they felt it was more efficient to select con-
tributors than train them or believed that the particular
qualities required of contributors were not readily amen-
able to development via training. Informants were more
receptive to training researchers in PPI. In contrast to PPI
contributors, most researchers had either received training
or indicated that they would find it helpful. Nevertheless,
a sizable minority did not think training would be helpful
because they had learnt about PPI ‘on the job’ or felt that
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tributors also saw a fairly limited role for training re-
searchers in PPI, although they did point to the use of
plain English and clarity about PPI contributor roles as
specific areas in which researchers could benefit from
training. For reasons which we outline below, despite the
reticence towards training that we found, we caution
against interpreting our findings as evidence to abandon
PPI training. However, the findings do point to ways in
which the current conceptualisation, design, promotion
and delivery of training could be enhanced.
Previous research and implications
There have been few previous empirical studies of PPI
training either for researchers or PPI contributors, al-
though training has generally been recommended for
both groups [7,26,27]. While not specific to clinical tri-
als, previous research has highlighted potential areas for
training for both PPI contributors, such as the aims, de-
sign and methods of research, supporting PPI activities
and facilitating partnerships within the research team
[27]. In showing that the appetite for PPI training is lim-
ited, particularly for PPI contributors, our findings diverge
from previous research, which found that researchers and
PPI contributors were in favour of training [27,28]. This
divergence may reflect differences in sampling between
previous work and ours, and particularly our focus on
clinical trials. Informants in our study knew each other
and their reluctance towards training could reflect a con-
cern to avoid implying criticism of their colleagues, as well
as themselves. Nevertheless, it is worth noting that previ-
ous research has tended to seek informants’ views on
training in general, whereas we sought informants’ views
about training both for themselves and for the researcher
or PPI contributor with whom they worked. Interestingly,
we found informants were more receptive to training
when speaking of ‘others’ outside their trials. Some of our
informants also struggled to imagine what the content
of training might be. Therefore, at the very least, our
findings indicate that those providing PPI training and
wishing to improve its uptake need to articulate what
both researchers and contributors can expect to gain
from training.
Researchers also questioned what evidence was available
on ‘how to do PPI’ and thereby to inform training. Such
evidence is currently limited, at least in part because the
promotion of PPI activity in research, rather than its
evaluation, has been the focus of much of the published
literature [15]. In separate articles from the EPIC study,
we have described researchers’ and PPI contributors’ ac-
counts of how the impact of PPI can be enhanced within
trials (LD et al. unpublished work) and the lessons that re-
searchers and PPI contributors learnt through their PPI
activities [18]. This and similar evidence from those at thefrontline of PPI practice could contribute to the evidence
base for training and inform its design and delivery.
Some informants, particularly researchers, were con-
cerned that training could hamper contributors’ ability
to provide a patient perspective. While such concerns
need to be taken seriously, it is possible to envisage ways
that training could support rather than detract from this
ability. Indeed, how to maintain a patient perspective
could be an explicit focus of education for PPI. More
fundamentally, our findings have implications for how
PPI training is conceptualised. The pronounced reluc-
tance that we identified regarding training for PPI con-
tributors, and informants’ preferences for ‘conversation’
over ‘training’, align with the emphasis informants gave
to establishing good relationships between the PPI con-
tributors and the research team (LD et al. unpublished
work). If a priority is to establish relationships, it is per-
haps not surprising that informants saw engaging in mu-
tual conversation as a more natural way to develop good
working relationships with each other than engaging in
training. The term training is often associated with the ac-
quisition of technical or practical skills, and it may be that
alternative types of educational provision such as action
learning sets [29,30] and coaching [31] are more suited to
learning about PPI. Researchers and contributors may
welcome such changes to educational provision for PPI.
However, given the rather implicit and one-way nature of
induction for PPI contributors as it was seemingly prac-
tised in the EPIC trials, our findings also point to the need
for a more structured approach to induction, as well as
the need to provide opportunities for contributors to ne-
gotiate their roles with researchers.
Our study also indicates the training needs that re-
searchers and PPI contributors identified (summarised
in Table 3). While these are similar to training needs
that have been previously identified [27], it is notable
that informants in our study tended to speak of training
for PPI contributors in terms of learning ‘how to do re-
search’ whereas training for researchers was spoken of
more broadly and included learning ‘how to do PPI’.
This raises questions about what should be the aims of
PPI training for both contributors and researchers, and
about how these aims are communicated. Given that
some PPI contributors lacked clarity regarding their roles,
provision that helps both researchers and PPI contributors
to learn about ‘how to do PPI’ would be beneficial. The
perception that training for PPI contributors focuses on
‘how to do research’ may be the source of some of the re-
luctance that surrounded training; how much contributors
need to know about research in order to be effective in
their roles requires serious consideration. Regarding deliv-
ery, our informants also described training as something
that was delivered separately for PPI contributors and
researchers. However, reflecting their emphasis on the
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standing of roles, our findings support previous sugges-
tions that training should allow contributors and
researchers to learn from each other [7]. Indeed, consid-
eration might be given to training PPI contributors and
researchers side-by-side.
As well as posing some questions for PPI training, our
findings also raise questions about the selection of PPI
contributors. Researchers indicated how they worked to
select PPI contributors with certain attributes, yet recog-
nised that this brought into question the claim that such
contributors could voice the patient perspective. Individ-
uals who are educated and articulate have been found to
be particularly likely to volunteer as PPI contributors
[32]. As many of our informants indicated, such PPI con-
tributors may not be in a position to speak for those from
less advantaged backgrounds. There is a danger that when
combined with reluctance towards training contributors,
PPI contributor selection practices, if reproduced across
many studies, could gradually mould research to the pref-
erences of advantaged groups. There are also indications
that PPI contributors with higher levels of education may
be prone to over identify with the perspectives of re-
searchers rather than challenging them [32]. Therefore,
while our informants did not themselves identify the se-
lection of PPI contributors as a training need, our findings
indicate that it is an area in which researchers could bene-
fit from educational provision. Informants in our study
did, nevertheless, point to the importance of involving
both professional and lay PPI contributors, the former
in managerial or oversight roles, and the latter in re-
sponsive roles via patient advisory panels. Such mixed
models of PPI could help to ameliorate these difficulties
and address the multiple functions required of PPI
within clinical trials.
Strengths and limitations
To our knowledge, this the first study to interview re-
searchers and PPI contributors who had no experience
of training as well as those who had such experience.
Our study provides insights about how PPI training
could be developed to enhance its relevance and uptake
for both contributors and researchers. By exploring train-
ing needs in the context of informants’ experiences of PPI
activity, rather than focussing narrowly on training, our
study has also identified some potential topics for training
beyond those articulated by our informants. The sample
included informants who had previous experience of PPI
as well as those without such experience. While there
were indications that those with previous experience of
PPI would have little to gain from training, in interpreting
informants’ accounts, it seems relevant to note that re-
search in a variety of educational contexts has indicated
that experience alone is not necessarily the best teacher[33,34] and that individuals are not necessarily accurate in
assessing their own knowledge and skills [35]. This raises
an important limitation: our study was not intended to
formally assess informants’ knowledge and understanding
of PPI or their skills in implementing PPI. Such assess-
ment would almost certainly identify additional training
needs. While the perceptions of researchers and contribu-
tors are important to inform future educational provision
for PPI, assessment of informants’ PPI knowledge and
skills would be valuable to address wider questions about
the effectiveness and value of PPI training. Our study was
retrospective and it is possible that prospective work
would identify further training needs. Also, informants’ ac-
counts of training may have been shaped by their percep-
tions of the success or otherwise of the trial. All the
interviewed PPI contributors had been involved in man-
agerial or oversight roles, and further research is needed
on training for those in responsive roles. As we note
above, informants’ reluctance regarding training for them-
selves and their colleagues may have been a way to avoid
implying criticism of both parties. However, as we report
elsewhere [18], both researchers and contributors gave
critical accounts of aspects of their own and their col-
leagues’ approach to PPI, and it seems unlikely that reti-
cence to criticise would manifest only in relation to
training. The reluctance that we found may also reflect a
sense of being too busy to participate in training, which
might, in turn, be indicative of a propensity to devalue PPI
[23], although we found no evidence that the attitudes of
researchers to PPI were linked to their views of training.
PPI contributors also expressed reluctance towards train-
ing, yet it seems implausible that this could be attributed
to them holding unfavourable attitudes to PPI.
Our sample was drawn from a wider cohort study and
survey, and this enabled us to provide more information
about our sample than is perhaps typical for qualitative
studies. Although we aimed to purposively sample infor-
mants to gain a diversity of views, we ended up inviting
almost all of those who indicated willingness to be inter-
viewed. Compared to the wider sample of CIs in our
survey, the survey responses of the sub-sample that we
interviewed indicated that they were slightly more
favourably inclined to PPI than those CIs who were not
interviewed. However, it would be epistemologically in-
appropriate to assume that survey responses can be
taken as a ‘true’ point from which to assess the adequacy
of our sample [36]. As we also report elsewhere (CG et al.
currently unpublished work), regardless of their survey
responses, CIs in the interviewed sample expressed a
diversity of views about PPI and some were sceptical
about its value. Finally, with one exception, our access to
PPI contributors was limited to those whose contact de-
tails were provided by CIs. The relationships between
interviewed contributors and researchers might have been
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is therefore possible that contributors and researchers de-
veloped a shared mindset that manifested as reluctance
towards training. Nevertheless, members of both groups
gave critical accounts of the other groups’ approaches to
PPI so it seems unlikely that either group struggled to
articulate their own perspectives regarding training.
Conclusions
While informants believed that training researchers in
PPI was useful to an extent, they saw little or no need to
provide training for PPI contributors. They regarded
such training as unnecessary and as limiting the ability
of PPI contributors to offer an authentic patient per-
spective. Informants regarded informal conversational
approaches to helping contributors learn about their
roles within trials as more appropriate than providing
training. Our study was not intended to address ques-
tions about the effectiveness of training and should not
be interpreted as providing evidence that educational
provision for PPI be abandoned. Rather, in pointing to
the need for further consideration to be given to how
training is conceptualised, designed, promoted and de-
livered, the findings will be useful to those who wish to
enhance the uptake and relevance of PPI training. The
findings also indicate the value of providing flexible, in-
formal induction and learning opportunities in ways
that flow from researchers’ and contributors’ needs and
preferences. However, instead of providing training, we
found that researchers preferred to select PPI contribu-
tors who possessed certain qualities, despite recognising
that this raised questions about how well placed such
individuals were to speak for those from very different
backgrounds to their own. In order to ensure that clin-
ical trials benefit from a diversity of patient perspec-
tives, the research community needs to give further
consideration to processes for selecting PPI contribu-
tors, to the potential role of training in widening the
pool of available PPI contributors and to the value of
different models of implementing PPI.
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